| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/19/1997 | CA2273983A1 Process for the preparation of 9-deazaguanine derivatives |
| 06/19/1997 | CA2240115A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240111A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240048A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2239991A1 Modified vegf antisense oligonucleotides |
| 06/19/1997 | CA2239908A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | CA2239293A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0778921A1 Pumping device |
| 06/18/1997 | EP0778851A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 06/18/1997 | EP0778849A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/18/1997 | EP0778848A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 06/18/1997 | EP0778845A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids |
| 06/18/1997 | EP0778844A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes |
| 06/18/1997 | EP0778843A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 06/18/1997 | EP0778842A1 Mammalian telomerase |
| 06/18/1997 | EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity |
| 06/18/1997 | EP0778774A2 New use of prostaglandins |
| 06/18/1997 | EP0778731A1 Ionene polymers containing biologically-active anions |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | EP0616609B1 Nitroaniline derivatives and their use as antitumor agents |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1152302A Retinoic acid X-receptor ligands |
| 06/18/1997 | CN1152251A Isolated nucleic acid sequence coding for a tumor rejection antigen presented by HLA-A2 |
| 06/18/1997 | CN1151865A Cancer chemopreventive agent |
| 06/18/1997 | CN1035177C Prep. of 20-methyl-substituted vitamin D-derivatives |
| 06/17/1997 | US5639887 MDR reversal agents |
| 06/17/1997 | US5639884 Antitumor agents |
| 06/17/1997 | US5639881 Synthesis and elucidation of pyrimido (4,5-Q) quinazoline derivatives |
| 06/17/1997 | US5639872 Human VEGF-specific oligonucleotides |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639749 Inhibitors of glycinamide ribonucleotide formyl transferase; antitumor agents |
| 06/17/1997 | US5639747 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/17/1997 | US5639746 Inhibitors of metalloprotease |
| 06/17/1997 | US5639745 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
| 06/17/1997 | US5639736 Reducing neovascularization by administering through the eye |
| 06/17/1997 | US5639735 Antitumor antibiotic compounds: hayumicins and analogs thereof |
| 06/17/1997 | US5639728 Antineoplastic peptide |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639712 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639621 Immunoreactive with a polymorphic epithelial mucin antigen |
| 06/17/1997 | US5639600 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 06/12/1997 | WO1997021104A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020919A1 Materials and methods for converting dna to co-dna |
| 06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | WO1997020843A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 06/12/1997 | WO1997020842A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 06/12/1997 | WO1997020835A1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy |
| 06/12/1997 | WO1997020824A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020564A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) |
| 06/12/1997 | WO1997011667A3 Therapeutic applications using horse serum |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239709A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238306A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2236913A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0778024A1 Oral or intramuscular treatment of pancreatic cancer with water-insoluble S-Camptothecin of the closed lactone ring form |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777680A1 Urokinase receptor ligands |
| 06/11/1997 | EP0777670A1 Substituted camptothecin derivatives and process for their preparation |
| 06/11/1997 | EP0777667A1 Cyclic benzazepine urea derivatives with aggregation-inhibiting effect |
| 06/11/1997 | EP0777665A1 Hemoregulatory compounds |
| 06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
| 06/11/1997 | EP0777498A1 Conjugates made of metal complexes and oligonucleotides |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 06/11/1997 | EP0777484A1 Intravenous alendronate formulations |
| 06/11/1997 | EP0777476A1 Methods of inhibiting endometrial cancer |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/11/1997 | EP0723442A4 Lactone compounds for treating patients with precancerous lesions |
| 06/11/1997 | EP0700395B1 Indole derivatives as steroid 5-alpha-reductase inhibitors |
| 06/11/1997 | EP0662964B1 Heterocyclic amines having calmodulin antagonist properties |